06924264 is referenced by 49 patents and cites 17 patents.

Novel modified exendins and exendin agonist analogs having an exendin or exendin agonist analog linked to one or more polyethylene glycol polymers, for example, and related formulations and dosages and methods of administration thereof are provided. These modified exendins and exendin agonist analogs, compositions and methods are useful in treating diabetes and conditions that would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying or inhibiting food intake.

Title
Modified exendins and exendin agonists
Application Number
9/561226
Publication Number
6924264 (B1)
Application Date
April 28, 2000
Publication Date
August 2, 2005
Inventor
Andrew A Young
San Diego
CA, US
Kathryn S Prickett
San Diego
CA, US
Agent
Arnold & Porter
Assignee
Amylin Pharmaceuticals
CA, US
IPC
A61K 038/22
View Original Source